170 related articles for article (PubMed ID: 21064090)
1. Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form.
Mongaret C; Alexandre J; Thomas-Schoemann A; Bermudez E; Chéreau C; Nicco C; Goldwasser F; Weill B; Batteux F; Lemare F
Int J Cancer; 2011 Aug; 129(4):791-8. PubMed ID: 21064090
[TBL] [Abstract][Full Text] [Related]
2. ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
Moss ML; Powell G; Miller MA; Edwards L; Qi B; Sang QX; De Strooper B; Tesseur I; Lichtenthaler SF; Taverna M; Zhong JL; Dingwall C; Ferdous T; Schlomann U; Zhou P; Griffith LG; Lauffenburger DA; Petrovich R; Bartsch JW
J Biol Chem; 2011 Nov; 286(47):40443-51. PubMed ID: 21956108
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
Chang L; Gong F; Cui Y
Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
[TBL] [Abstract][Full Text] [Related]
4. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
5. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
[TBL] [Abstract][Full Text] [Related]
6. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
7. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.
Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339
[TBL] [Abstract][Full Text] [Related]
8. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis.
Caolo V; Swennen G; Chalaris A; Wagenaar A; Verbruggen S; Rose-John S; Molin DG; Vooijs M; Post MJ
Angiogenesis; 2015 Jan; 18(1):13-22. PubMed ID: 25218057
[TBL] [Abstract][Full Text] [Related]
9. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions.
Mazzocca A; Coppari R; De Franco R; Cho JY; Libermann TA; Pinzani M; Toker A
Cancer Res; 2005 Jun; 65(11):4728-38. PubMed ID: 15930291
[TBL] [Abstract][Full Text] [Related]
10. Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression.
Twito T; Chen Z; Khatri I; Wong K; Spaner D; Gorczynski R
Leuk Res; 2013 Jul; 37(7):816-21. PubMed ID: 23643150
[TBL] [Abstract][Full Text] [Related]
11. ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices.
Kwak HI; Mendoza EA; Bayless KJ
Matrix Biol; 2009 Oct; 28(8):470-9. PubMed ID: 19666115
[TBL] [Abstract][Full Text] [Related]
12. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW
Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608
[TBL] [Abstract][Full Text] [Related]
14. ADAM9 silencing inhibits breast tumor cell invasion in vitro.
Micocci KC; Martin AC; Montenegro Cde F; Durante AC; Pouliot N; Cominetti MR; Selistre-de-Araujo HS
Biochimie; 2013 Jul; 95(7):1371-8. PubMed ID: 23499592
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis.
Shintani Y; Higashiyama S; Ohta M; Hirabayashi H; Yamamoto S; Yoshimasu T; Matsuda H; Matsuura N
Cancer Res; 2004 Jun; 64(12):4190-6. PubMed ID: 15205330
[TBL] [Abstract][Full Text] [Related]
16. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.
Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J
Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701
[TBL] [Abstract][Full Text] [Related]
17. TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS.
Noy PJ; Yang J; Reyat JS; Matthews AL; Charlton AE; Furmston J; Rogers DA; Rainger GE; Tomlinson MG
J Biol Chem; 2016 Feb; 291(7):3145-57. PubMed ID: 26668317
[TBL] [Abstract][Full Text] [Related]
18. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
Parkin E; Harris B
J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255
[TBL] [Abstract][Full Text] [Related]
19. Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9.
Franzke CW; Bruckner-Tuderman L; Blobel CP
J Biol Chem; 2009 Aug; 284(35):23386-96. PubMed ID: 19574220
[TBL] [Abstract][Full Text] [Related]
20. Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10.
Prox J; Willenbrock M; Weber S; Lehmann T; Schmidt-Arras D; Schwanbeck R; Saftig P; Schwake M
Cell Mol Life Sci; 2012 Sep; 69(17):2919-32. PubMed ID: 22446748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
